Eris Biotech

Eris Biotech is a biotechnology company focused on developing innovative treatments for cancer by harnessing the power of the immune system. The company has identified a significant challenge in cancer treatment: the ability of cancer cells to evade detection and destruction by the immune system. This immune evasion is a major factor contributing to the failure of traditional cancer therapies. In response, Eris Biotech has developed a first-in-class small-molecule inhibitor designed to block this immune evasion pathway, thus reactivating the immune response against cancer cells.